Skip to main content
ALLR logo
ALLR
(NASDAQ)
Allarity Therapeutics, Inc.
$1.16-- (--)
Loading... - Market loading

Allarity Therapeutics (ALLR) Key Statistics & Financial Metrics

Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.

Stock Valuation Metrics

Market value, earnings multiples, and pricing ratios

Market Valuation & Earnings Multiples

Market capitalization, P/E ratios, and enterprise value

Market Cap17.10M
Enterprise Value1.15M

Price-Based Ratios

Valuation ratios based on stock price

Price/Book (mrq)1.39
Price/Tangible Book (mrq)1.39

Enterprise Value Ratios

EV-based valuation multiples

EV/Earnings-0.08
EV/EBITDA-0.08
EV/EBIT-0.08
EV/FCF-0.08

Stock Price

Current price, 52-week range, and moving averages

Current Price$1.16
1-Day Change3.67%
52-Week High$2.35
52-Week Low$0.61
52-Week Change24.16%
YTD Change-0.88%
1-Year Change27.89%
50-Day MA$1.06
200-Day MA$1.19
Avg Volume (30 day)55.11K

Share Statistics

Outstanding shares, float, and per-share metrics

Shares Outstanding14.74M
Book Value per Share$0.81
Net Cash per Share$1.05
FCF per Share$-1.02

Profitability & Financial Performance

Profit margins, return metrics, and earnings analysis

Profit Margins

Profitability margins across income statement

Return on Investment Metrics

ROE, ROA, ROIC, and capital efficiency ratios

Return on Equity (ttm)-127.47%
Return on Assets (ttm)-73.62%
Return on Capital Employed (ttm)-125.80%

Income Statement (TTM)

Trailing twelve months revenue and earnings

Revenue0.00
Gross Profit0.00
Operating Income-17.00M
Pretax Income-15.31M
Net Income-15.31M
EBITDA-15.09M
EBIT-15.11M
Diluted EPS$-1.04

Cash Flow (TTM)

Operating cash flow and free cash flow metrics

Operating Cash Flow-14.78M
Capital Expenditures298.00K
Free Cash Flow-15.08M

Growth Rates (YoY)

Year-over-year growth metrics

Financial Health & Dividends

Balance sheet analysis, debt ratios, and dividend metrics

Assets & Cash

Total assets and cash positions

Total Assets (mrq)20.80M
Cash & Securities (mrq)16.89M
Net Cash (mrq)15.51M
Net Cash per Share$1.05

Debt & Liabilities

Liabilities, debt, equity, and working capital

Total Debt (mrq)1.39M
Working Capital (mrq)11.68M
Total Equity (mrq)12.01M
Book Value per Share$0.81

Liquidity & Leverage

Liquidity, leverage, and debt coverage ratios

Current Ratio (mrq)2.33
Quick Ratio (mrq)2.33
Debt/Equity (mrq)0.12

Dividend History & Payout Analysis

Dividend yield, payout ratios, and growth metrics

Dividend per Share (TTM)$0.00
Dividend Yield0.00%

Yield Metrics

Earnings, FCF, buyback, and shareholder yields

Earnings Yield-91.92%
FCF Yield-90.54%
Buyback Yield0.85%
Total Shareholder Yield0.85%

Financial Health Scores

Risk assessment and quality metrics

Altman Z-Score-9.12
Piotroski F-Score1/9

Frequently Asked Questions About Allarity Therapeutics Statistics

What are the key financial metrics for ALLR?

Allarity Therapeutics, Inc. (ALLR) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.

What is ALLR's valuation analysis?

The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Allarity Therapeutics is overvalued or undervalued.

How do I read ALLR's profitability ratios?

Allarity Therapeutics's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.

What do ALLR's debt ratios indicate?

The financial health section shows Allarity Therapeutics's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.

What is ALLR's dividend analysis?

The dividend section covers Allarity Therapeutics's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.